Works matching AU Saka, Hideo

Results: 88
    1

    A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

    Published in:
    2018
    By:
    • Yoshihito Kogure;
    • Hideo Saka;
    • Yuichi Takiguchi;
    • Shinji Atagi;
    • Takayasu Kurata;
    • Noriyuki Ebi;
    • Akira Inoue;
    • Kaoru Kubota;
    • Mitsuhiro Takenoyama;
    • Takashi Seto;
    • Akiko Kada;
    • Takeharu Yamanaka;
    • Masahiko Ando;
    • Nobuyuki Yamamoto;
    • Akihiko Gemma;
    • Yukito Ichinose;
    • Kogure, Yoshihito;
    • Saka, Hideo;
    • Takiguchi, Yuichi;
    • Atagi, Shinji
    Publication type:
    journal article
    2
    3
    4
    5

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    6
    7
    8

    Randomized Phase I Study of Standard-fractionatedor Accelerated-hyperfractionated Radiotherapy with Concurrent Cisplatinand Vindesine for Unresectable Non-small Cell Lung Cancer: a Reportof Japan Clinical Oncology Group Study (JCOG 9601).

    Published in:
    Japanese Journal of Clinical Oncology, 2001, v. 31, n. 10, p. 488, doi. 10.1093/jjco/hye106
    By:
    • Tsuchiya, Satoshi;
    • Ohe, Yuichiro;
    • Sugiura, Takahiko;
    • Fuwa, Nobukazu;
    • Kitamoto, Yoshizumi;
    • Mori, Kiyoshi;
    • Kobayashi, Hideo;
    • Nakata, Koichiro;
    • Sawa, Toshiyuki;
    • Hirai, Kazuya;
    • Etoh, Takashi;
    • Saka, Hideo;
    • Saito, Atsushi;
    • Fukuda, Haruhiko;
    • Ishizuka, Naoki;
    • Saijo, Nagahiro
    Publication type:
    Article
    9
    10

    Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

    Published in:
    2013
    By:
    • Okamoto, Isamu;
    • Aoe, Keisuke;
    • Kato, Terufumi;
    • Hosomi, Yukio;
    • Yokoyama, Akira;
    • Imamura, Fumio;
    • Kiura, Katsuyuki;
    • Hirashima, Tomonori;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Okamoto, Hiroaki;
    • Saka, Hideo;
    • Yamamoto, Nobuyuki;
    • Yoshizuka, Naoto;
    • Sekiguchi, Risa;
    • Kiyosawa, Kazuhiro;
    • Nakagawa, Kazuhiko;
    • Tamura, Tomohide
    Publication type:
    Journal Article
    11

    Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

    Published in:
    Investigational New Drugs, 2013, v. 31, n. 5, p. 1275, doi. 10.1007/s10637-013-9941-z
    By:
    • Okamoto, Isamu;
    • Aoe, Keisuke;
    • Kato, Terufumi;
    • Hosomi, Yukio;
    • Yokoyama, Akira;
    • Imamura, Fumio;
    • Kiura, Katsuyuki;
    • Hirashima, Tomonori;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Okamoto, Hiroaki;
    • Saka, Hideo;
    • Yamamoto, Nobuyuki;
    • Yoshizuka, Naoto;
    • Sekiguchi, Risa;
    • Kiyosawa, Kazuhiro;
    • Nakagawa, Kazuhiko;
    • Tamura, Tomohide
    Publication type:
    Article
    12

    Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

    Published in:
    2013
    By:
    • Okamoto, Isamu;
    • Aoe, Keisuke;
    • Kato, Terufumi;
    • Hosomi, Yukio;
    • Yokoyama, Akira;
    • Imamura, Fumio;
    • Kiura, Katsuyuki;
    • Hirashima, Tomonori;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Okamoto, Hiroaki;
    • Saka, Hideo;
    • Yamamoto, Nobuyuki;
    • Yoshizuka, Naoto;
    • Sekiguchi, Risa;
    • Kiyosawa, Kazuhiro;
    • Nakagawa, Kazuhiko;
    • Tamura, Tomohide
    Publication type:
    Correction Notice
    13
    14
    15
    16
    17
    18

    Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2013, v. 188, n. 8, p. 985, doi. 10.1164/rccm.201301-0079OC
    By:
    • Yuichiro Shindo;
    • Ryota Ito;
    • Daisuke Kobayashi;
    • Masahiko Ando;
    • Motoshi Ichikawa;
    • Akira Shiraki;
    • Yasuhiro Goto;
    • Yasutaka Fukui;
    • Mal Iwaki;
    • Junya Okumura;
    • Ikuo Yamaguchi;
    • Tetsuya Yagi;
    • Yoshimasa Tanikawa;
    • Yasuteru Sugino;
    • Joe Shindoh;
    • Tomohiko Ogasawara;
    • Fumio Nomura;
    • Hideo Saka;
    • Masashi Yamamoto;
    • Hiroyuki Taniguchi
    Publication type:
    Article
    19
    20

    Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101).

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2216, doi. 10.1007/s10147-021-02012-9
    By:
    • Yamaguchi, Masafumi;
    • Tada, Hirohito;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Yokoi, Kohei;
    • Katakami, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Oda, Makoto;
    • Ohta, Mitsunori;
    • Sawa, Toshiyuki;
    • Yamashita, Motohiro;
    • Iked, Norihiko;
    • Saka, Hideo;
    • Higashiyama, Masahiko;
    • Nomori, Hiroaki;
    • Semba, Hiroshi;
    • Negoro, Shunichi;
    • Chiba, Yasutaka;
    • Shimokawa, Mototsugu;
    • Fukuoka, Masahiro
    Publication type:
    Article
    21

    Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z
    By:
    • Sugawara, Shunichi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Nokihara, Hiroshi;
    • Ohe, Yuichiro;
    • Nishio, Makoto;
    • Takahashi, Toshiaki;
    • Goto, Koichi;
    • Maemondo, Makoto;
    • Ichinose, Yukito;
    • Seto, Takashi;
    • Sakai, Hiroshi;
    • Gemma, Akihiko;
    • Imamura, Fumio;
    • Shingyoji, Masato;
    • Saka, Hideo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Okamoto, Isamu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816
    By:
    • Sugawara, Shunichi;
    • Tanaka, Kentaro;
    • Imamura, Fumio;
    • Yamamoto, Nobuyuki;
    • Nishio, Makoto;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Tanaka, Hiroshi;
    • Fukuhara, Tatsuro;
    • Nakahara, Yasuharu;
    • Kurata, Takayasu;
    • Katakami, Nobuyuki;
    • Okada, Morihito;
    • Horinouchi, Hidehito;
    • Udagawa, Hibiki;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Saka, Hideo;
    • Tokito, Takaaki;
    • Hosomi, Yukio
    Publication type:
    Article
    32

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    33
    34

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    35
    36

    Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225
    By:
    • Hida, Toyoaki;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Ohe, Yuichiro;
    • Nokihara, Hiroshi;
    • Sakai, Hiroshi;
    • Satouchi, Miyako;
    • Nakagawa, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Isobe, Hiroshi;
    • Fujita, Shiro;
    • Tanaka, Hiroshi;
    • Minato, Koichi;
    • Takahashi, Toshiaki;
    • Maemondo, Makoto;
    • Takeda, Koji;
    • Saka, Hideo;
    • Goto, Koichi;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article
    37
    38

    Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 7, p. 2343, doi. 10.1002/cam4.2897
    By:
    • Tamiya, Akihiro;
    • Koh, Yasuhiro;
    • Isa, Shun‐ichi;
    • Kubo, Akihito;
    • Ando, Masahiko;
    • Saka, Hideo;
    • Yoshimoto, Naoki;
    • Takeo, Sadanori;
    • Adachi, Hirofumi;
    • Tagawa, Tsutomu;
    • Kawashima, Osamu;
    • Yamashita, Motohiro;
    • Kataoka, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Takeuchi, Yukiyasu;
    • Watanabe, Katsuya;
    • Matsumura, Akihide;
    • Kawaguchi, Tomoya
    Publication type:
    Article
    39

    Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 11, p. 5183, doi. 10.1002/cam4.2411
    By:
    • Horinouchi, Hidehito;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Saka, Hideo;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Sumiyoshi, Naoki
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.

    Published in:
    2017
    By:
    • Hideo Saka;
    • Chiyoe Kitagawa;
    • Yukito Ichinose;
    • Mitsuhiro Takenoyama;
    • Hidenori Ibata;
    • Tatsuo Kato;
    • Koji Takami;
    • Motohiro Yamashita;
    • Tadashi Maeda;
    • Sadanori Takeo;
    • Hitoshi Ueda;
    • Kan Okabayashi;
    • Seiji Nagashima;
    • Tadayuki Oka;
    • Hidenori Kouso;
    • Seiichi Fukuyama;
    • Kentaro Yoshimoto;
    • Mototsugu Shimokawa;
    • Saito, Akiko M.;
    • Suminobu Ito
    Publication type:
    journal article
    48
    49
    50